Leavitt Partners Blog

Leavitt Partners Future Frame Series – Political Checkpoint: An Inflection Point
July 2, 2021

On June 24, Leavitt Partners hosted a LinkedIn Live broadcast titled “Political Checkpoint: An Inflection Point” featuring Josh Trent, Jennifer Colamonico, and moderated by Andrew Croshaw. Josh and Jen discussed the political inflection point we are in as the country emerges from the pandemic and the Administration and Congress work on health policy priorities ahead of the 2022 midterms. The speakers also shared insights into how health policy developments—including those that […]

Read More >
Leavitt Partners Future Frame Series: Strategic Approaches To Reducing Health Disparities At The State Level
June 17, 2021

Leavitt Partners’ CEO Andrew Croshaw recently moderated a discussion between Patricia Doxey and Dulce Diez, the Director of the Office of Health Disparities (OHD) for the Utah Department of Health, highlighting key opportunities to reduce health disparities. The panel discussed the market flaws revealed by COVID-19 and Utah OHD’s framework for addressing health inequities, which […]

Read More >
How 4 Health Plans Are Taking Innovative Approaches To Addressing Food As Medicine
May 12, 2021

Nutrition’s role in better health outcomes (both physical and mental) and potential cost savings is spurring increased innovation within the healthcare sector. Providers are increasingly interested in how to best connect their patients to quality food, which means that health plans are figuring if (and how) they will reimburse for increasing nutrition security. Here are […]

Read More >
Subphenotyping and Strengthening the ROI for the National Diabetes Prevention Program
May 7, 2021

Written By: Rebecca Nielsen May 07, 2021 Enrolling only the subset of individuals with prediabetes who are most likely to progress to Type 2 could strengthen the case for covering the National DPP.  The publication of the Wagner, et al study in Nature Magazine portends potential changes in the treatment of prediabetes, as well as the return-on-investment story […]

Read More >
Subphenotyping And Strengthening The ROI For The National Diabetes Prevention Program
May 7, 2021

Enrolling only the subset of individuals with prediabetes who are most likely to progress to Type 2 could strengthen the case for covering the National DPP.  The publication of the Wagner, et al study in Nature Magazine portends potential changes in the treatment of prediabetes, as well as the return-on-investment story for the National Diabetes Prevention Program […]

Read More >
Top Primary Care Innovators To Watch (Part 2 Of 2)
May 4, 2021

Written By: Adam Child May 04, 2021 In the previous blog post on primary care innovators, we talked about why primary care is an exciting space to watch. We talked about CareMore and ChenMed, two innovators in the space. In today’s post, we will provide an overview of three additional innovators that will impact how primary care […]

Read More >
Top Primary Care Innovators To Watch (Part 2 Of 2)
May 4, 2021

In the previous blog post on primary care innovators, we talked about why primary care is an exciting space to watch. We talked about CareMore and ChenMed, two innovators in the space. In today’s post, we will provide an overview of three additional innovators that will impact how primary care is delivered across the nation: Iora […]

Read More >
Top Primary Care Innovators To Watch (Part 1 Of 2)
April 27, 2021

Written By: Adam Child April 27, 2021 Primary care has long been attributed as being the life blood of the American healthcare system and serves as the foundation for referrals and patients for any large health system. Primary Care has traditionally been built upon a fee-for-service (FFS) model and has experienced a relatively low reimbursement compared […]

Read More >